CECAD Microsite

Tim Rehkämper receives funding through Köln Fortune

10/19/2016

Tim Rehkämper receives funding through Köln Fortune

With the Köln Fortune Grant the University of Cologne supports highly motivated medical students during their MD thesis. Tim Rehkämper will focus on Lymphomagenesis by using mouse models of diffuse large B-cell Lymphoma in order to understand the intracellular pathways and the influence of mutations within these pathways affecting disease development and therapy response. These models will also be used as a preclinical platform for the development of novel, targeted treatment approaches.